Estrogen in combination with 5-azacitidine up-regulates p75NTR expression and induces apoptosis in 22Rv1 prostate cancer cells

Molecular Medicine Reports

Volumn 2, Issue 5, 2009, Pages 831-836

  Yu, Jian Di ^a,b   Yang, Kai ^a   Mao, Qi Qi ^a   Kong, De Bo ^a   Zheng, Xiang Yi ^a   Xie, Li Ping ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG HOSPITAL   (China)

Author keywords

Apoptosis; DNA demethylation; Estrogen; Estrogen receptor; p75NTR; Prostate cancer

Indexed keywords

ANDROGEN; AZACITIDINE; ESTROGEN; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROTROPHIN RECEPTOR P75;

APOPTOSIS; ARTICLE; CANCER CELL; CELL LINE; CELL NUCLEUS; HUMAN; HUMAN CELL; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION;

EID: 69249230978     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000180     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
2. Zhou J, Scholes J and Hsieh JT: Signal transduction targets in androgen-independent prostate cancer. Cancer Metastasis Rev 20: 351-362, 2001. (Pubitemid 34595276)
3. Huggins C and Hodges CV: Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 168: 9-12, 2002.
4. Carruba G, Pfeffer U, Fecarotta E, Coviello DA, D'Amato E, Lo Castro M, Vidali G and Castagnetta L: Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells. Cancer Res 54: 1190-1193, 1994. (Pubitemid 24108055)
5. Robertson CN, Roberson KM, Padilla GM, O'Brien ET, Cook JM, Kim CS and Fine RL: Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 88: 908-917, 1996. (Pubitemid 26230642)
6. Griffiths K: Estrogens and prostatic disease. International Prostate Health Council Study Group. Prostate 45: 87-100, 2000.
7. Lau KM, LaSpina M, Long J and Ho SM: Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 60: 3175-3182, 2000. (Pubitemid 30407914)
8. Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao Y, McNeal JE and Ho SM: Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. Am J Pathol 164: 2003-2012, 2004. (Pubitemid 38669349)
9. Walton TJ, Li G, Seth R, McArdle SE, Bishop MC and Rees RC: DNA demethylation and histone deacetylation inhibition cooperate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. Prostate 68: 210-222, 2008. (Pubitemid 351186233)
10. Delsite R and Djakiew D: Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: a role in selective neurotrophin stimulation of prostate epithelial cell growth. Prostate 41: 39-48, 1999. (Pubitemid 29390414)
11. MacGrogan D, Saint-Andre JP and Dicou E: Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. J Neurochem 59: 1381-1391, 1992.
12. Pflug B and Djakiew D: Expression of p75NTR in a human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death. Mol Carcinog 23: 106-114, 1998. (Pubitemid 28507420)
13. Allen J, Khwaja F, Byers S and Djakiew D: The p75NTR mediates a bifurcated signal transduction cascade through the NF kappa B and JNK pathways to inhibit cell survival. Exp Cell Res 304: 69-80, 2005. (Pubitemid 40222078)
14. Gibbs RB: Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann NY Acad Sci 743: 165-197, 1994.
15. Sohrabji F, Miranda RC and Toran-Allerand CD: Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 14: 459-471, 1994. (Pubitemid 24043906)
16. Green AR, Edwards RE, Greaves P and White IN: Comparison of the effect of oestradiol, tamoxifen and raloxifene on nerve growth factor-alpha expression in specific neonatal mouse uterine cell types using laser capture microdissection. J Mol Endocrinol 30: 1-11, 2003. (Pubitemid 36305252)
17. Gibbs RB: Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res 757: 10-16, 1997.
18. Festuccia C, Muzi P, Gravina GL, Millimaggi D, Speca S, Dolo V, Ricevuto E, Vicentini C and Bologna M: Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro. Int J Oncol 30: 193-200, 2007.
19. Linja MJ, Savinainen KJ, Tammela TL, Isola JJ and Visakorpi T: Expression of ERalpha and ERbeta in prostate cancer. Prostate 55: 180-186, 2003. (Pubitemid 36532396)
20. Leung YK, Gao Y, Lau KM, Zhang X and Ho SM: ICI 182, 780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-beta/NFkappaB crosstalk. Neoplasia 8: 242-249, 2006.
21. Hartley-Asp B, Deinum J and Wallin M: Diethylstilbestrol induces metaphase arrest and inhibits microtubule assembly. Mutat Res 143: 231-235, 1985. (Pubitemid 15012599)
22. Lakhani NJ, Sarkar MA, Venitz J and Figg WD: 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23: 165-172, 2003. (Pubitemid 36197457)
23. Scherr DS and Pitts WR Jr: The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer. J Urol 170: 1703-1708, 2003.
24. Ahmed M, Choksy S, Chilton CP, Munson KW and Williams JH: High dose intravenous oestrogen (fosfestrol) in the treatment of symptomatic, metastatic, hormone-refractory carcinoma of the prostate. Int Urol Nephrol 30: 159-164, 1998. (Pubitemid 28459636)
25. Mobley JA, L'Esperance JO, Wu M, Friel CJ, Hanson RH and Ho SM: The novel estrogen 17alpha-20Z-21-[(4-amino) phenyl]-19-norpregna-1,3,5(10),20-tetraene- 3,17beta-diol induces apoptosis in prostate cancer cell lines at nanomolar concentrations in vitro. Mol Cancer Ther 3: 587-595, 2004.
26. Pasquali D, Rossi V, Esposito D, Abbondanza C, Puca GA, Bellastella A and Sinisi AA: Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues. J Clin Endocrinol Metab 86: 2051-2055, 2001. (Pubitemid 32472918)
27. Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Strieker PD, Grygiel JJ, Gustafsson JA and Sutherland RL: Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 61: 5331-5335, 2001. (Pubitemid 32694904)
28. Li LC, Yeh CC, Nojima D and Dahiya R: Cloning and characterization of human estrogen receptor beta promoter. Biochem Biophys Res Commun 275: 682-689, 2000. (Pubitemid 30682934)
29. Yano H and Chao MV: Neurotrophin receptor structure and interactions. Pharm Acta Helv 74: 253-260, 2000. (Pubitemid 30182578)
30. Perez M, Regan T, Pflug B, Lynch J and Djakiew D: Loss of low-affinity nerve growth factor receptor during malignant transformation of the human prostate. Prostate 30: 274-279, 1997. (Pubitemid 27172840)
31. Pflug BR, Onoda M, Lynch JH and Djakiew D: Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 52: 5403-5406, 1992.
32. Djakiew D: Dysregulated expression of growth factors and their receptors in the development of prostate cancer. Prostate 42: 150-160, 2000. (Pubitemid 30056648)
33. Festuccia C, Gravina GL, Muzi P, Pomante R, Ventura L, Ricevuto E, Vicentini C and Bologna M: In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma. Prostate 67: 1255-1264, 2007.
34. Quann EJ, Khwaja F, Zavitz KH and Djakiew D: The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells. Cancer Res 67: 3254-3262, 2007. (Pubitemid 46724863)
35. Lovekamp-Swan T, Glendenning ML and Schreihofer DA: A high soy diet enhances neurotropin receptor and Bcl-XL gene expression in the brains of ovariectomized female rats. Brain Res 1159: 54-66, 2007. (Pubitemid 47064393)
36. Basak S and Hoffmann A: Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev 19: 187-197, 2008.